We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · October 03, 2019

Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients With Type 2 Diabetes

The Journal of Clinical Endocrinology and Metabolism

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Journal of Clinical Endocrinology and Metabolism
Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients With Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab. 2019 Sep 23;[EPub Ahead of Print], FS Yen, HC Wang, CW Pan, JC Wei, CC Hsu, CM Hwu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading